Search research articles
Contact Us
Filters
Showing results (41-50 of 124) with videos related to
Page
of 13
Sort By:
The Journal of Allergy and Clinical Immunology
|
January 12, 2000
In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation
C Tkaczyk, I Villa, R Peronet, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1992
Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels
Y Mahé, K Hirose, B Clausse, et al.
Human Immunology
|
April 1, 1996
CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells
C Flament, K Bellagha, A Rosenthal-Allieri, et al.
Human Immunology
|
November 1, 1996
TCR alpha/beta and TCR gamma/delta CD4-/CD8- HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells
F Mami-Chouaib, C Flament, C Asselin-Paturel, et al.
European Cytokine Network
|
March 1, 1997
Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells
V A Shatrov, J R Boelaert, S Chouaib, et al.
Immunology Today
|
November 14, 1997
The host-tumor immune conflict: from immunosuppression to resistance and destruction
S Chouaib, C Asselin-Paturel, F Mami-Chouaib, et al.
International Immunology
|
April 1, 2000
Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung
H Echchakir, I Vergnon, G Dorothée, et al.
Tissue Antigens
|
October 1, 1996
The renal cell carcinoma lysis by a specific cytotoxic T cell clone is independent of the Fas/Fas-L cytotoxic pathway
A Caignard, M Guillard, Z Cai, et al.
The Journal of Biological Chemistry
|
April 14, 1995
Evidence for the binding of a biologically active interleukin-2 to human alpha 2-macroglobulin
L G Legrès, F Pochon, M Barray, et al.
Cellular Immunology
|
December 1, 1993
IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of action
A Ammar, A M Bertoli, S Chouaib, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 124) with videos related to
Sort By:
Page
of 13
The Journal of Allergy and Clinical Immunology
|
January 12, 2000
In vitro and in vivo immunostimulatory potential of bone marrow-derived mast cells on B- and T-lymphocyte activation
C Tkaczyk, I Villa, R Peronet, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1992
Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels
Y Mahé, K Hirose, B Clausse, et al.
Human Immunology
|
April 1, 1996
CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells
C Flament, K Bellagha, A Rosenthal-Allieri, et al.
Human Immunology
|
November 1, 1996
TCR alpha/beta and TCR gamma/delta CD4-/CD8- HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells
F Mami-Chouaib, C Flament, C Asselin-Paturel, et al.
European Cytokine Network
|
March 1, 1997
Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells
V A Shatrov, J R Boelaert, S Chouaib, et al.
Immunology Today
|
November 14, 1997
The host-tumor immune conflict: from immunosuppression to resistance and destruction
S Chouaib, C Asselin-Paturel, F Mami-Chouaib, et al.
International Immunology
|
April 1, 2000
Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung
H Echchakir, I Vergnon, G Dorothée, et al.
Tissue Antigens
|
October 1, 1996
The renal cell carcinoma lysis by a specific cytotoxic T cell clone is independent of the Fas/Fas-L cytotoxic pathway
A Caignard, M Guillard, Z Cai, et al.
The Journal of Biological Chemistry
|
April 14, 1995
Evidence for the binding of a biologically active interleukin-2 to human alpha 2-macroglobulin
L G Legrès, F Pochon, M Barray, et al.
Cellular Immunology
|
December 1, 1993
IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of action
A Ammar, A M Bertoli, S Chouaib, et al.
Page
of 13